BioNTech SE (BNTX) Prepaid Assets (2018 - 2019)
BioNTech SE (BNTX) posted Prepaid Assets of $388517.6 for Q4 2019, up 119.61% on a QoQ basis from $176916.4 in Q4 2018, and up 119.61% year-over-year from $176916.4 in Q4 2018.
BioNTech SE (BNTX) has 2 years of Prepaid Assets data on file, last reported at $388517.6 in Q4 2019.
- In Q4 2019, Prepaid Assets rose 119.61% year-over-year to $388517.6; the TTM figure through Dec 2019 stood at $388517.6 (up 119.61% YoY), while the FY2019 annual figure was $388517.6, up 112.18% from the prior year.
- Prepaid Assets advanced to $388517.6 in Q4 2019, from $176916.4 in the prior quarter.
- Across five years, Prepaid Assets topped out at $388517.6 in Q4 2019 and bottomed at $176916.4 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 388,517.57 |
| Dec 31, 2018 | 176,916.45 |